Sharp Therapeutics Corp. (TSXV:SHRX)
Canada
· Delayed Price · Currency is CAD 1.850
0.00 (0.00%)
At close: Apr 30, 2025
Sharp Therapeutics Statistics
Total Valuation
TSXV:SHRX has a market cap or net worth of CAD 55.39 million. The enterprise value is 52.26 million.
| Market Cap | 55.39M |
| Enterprise Value | 52.26M |
Important Dates
| Earnings Date | n/a |
| Ex-Dividend Date | n/a |
Share Statistics
TSXV:SHRX has 29.94 million shares outstanding. The number of shares has increased by 107.12% in one year.
| Current Share Class | 29.94M |
| Shares Outstanding | 29.94M |
| Shares Change (YoY) | +107.12% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 3.42% |
| Owned by Institutions (%) | 0.70% |
| Float | 16.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 14.89 |
| P/TBV Ratio | 14.89 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -11.14 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -10.01 |
Financial Position
The company has a current ratio of 5.10, with a Debt / Equity ratio of 0.51.
| Current Ratio | 5.10 |
| Quick Ratio | 5.05 |
| Debt / Equity | 0.51 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.36 |
| Interest Coverage | -14.86 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -52.06% |
| Return on Invested Capital (ROIC) | -63.32% |
| Return on Capital Employed (ROCE) | -65.75% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | n/a |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 46.91 |
| Average Volume (20 Days) | 2,837 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.66M |
| Pretax Income | -4.69M |
| Net Income | -4.69M |
| EBITDA | -3.63M |
| EBIT | -3.66M |
| Earnings Per Share (EPS) | -0.52 |
Balance Sheet
The company has 5.01 million in cash and 1.89 million in debt, giving a net cash position of 3.12 million or 0.10 per share.
| Cash & Cash Equivalents | 5.01M |
| Total Debt | 1.89M |
| Net Cash | 3.12M |
| Net Cash Per Share | 0.10 |
| Equity (Book Value) | 3.72M |
| Book Value Per Share | 0.13 |
| Working Capital | 4.07M |
Cash Flow
In the last 12 months, operating cash flow was -5.20 million and capital expenditures -20,846, giving a free cash flow of -5.22 million.
| Operating Cash Flow | -5.20M |
| Capital Expenditures | -20,846 |
| Free Cash Flow | -5.22M |
| FCF Per Share | -0.17 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
TSXV:SHRX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -107.12% |
| Shareholder Yield | -107.12% |
| Earnings Yield | -8.47% |
| FCF Yield | -9.43% |
Stock Splits
The last stock split was on January 27, 2025. It was a reverse split with a ratio of 0.1.
| Last Split Date | Jan 27, 2025 |
| Split Type | Reverse |
| Split Ratio | 0.1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |